How Sensitive Are Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitors for Squamous Cell Carcinoma of the Lung Harboring EGFR Gene–Sensitive Mutations?-Reference-Cited by-同舟云学术

How Sensitive Are Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitors for Squamous Cell Carcinoma of the Lung Harboring EGFR Gene–Sensitive Mutations?

Published:2013-01 Issue:1 Volume:8 Page:89-95
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Hata Akito,Katakami Nobuyuki,Yoshioka Hiroshige,Kunimasa Kei,Fujita Shiro,Kaji Reiko,Notohara Kenji,Imai Yukihiro,Tachikawa Ryo,Tomii Keisuke,Korogi Yohei,Iwasaku Masahiro,Nishiyama Akihiro,Ishida Tadashi

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference44 articles.

1. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib;Lynch;N Engl J Med,2004

2. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy;Paez;Science,2004

3. Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers;Shigematsu;J Natl Cancer Inst,2005

4. Genetic heterogeneity of the epidermal growth factor receptor in non-small cell lung cancer cell lines revealed by a rapid and sensitive detection system, the peptide nucleic acid-locked nucleic acid PCR clamp;Nagai;Cancer Res,2005

5. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada;Therasse;J Natl Cancer Inst,2000

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Osimertinib inhibits brain metastases and improves long-term survival in a patient with advanced squamous cell lung cancer: a case report and literatures review;Frontiers in Oncology;2023-09-14

2. Efficacy of osimertinib for lung squamous cell carcinoma with de novo EGFR T790M‐positive: Case report and literature review;Thoracic Cancer;2023-08-28

3. Next‐generation sequencing clarified why first‐line treatment with osimertinib was ineffective in an autopsied case of EGFR‐mutated lung squamous cell carcinoma;Thoracic Cancer;2023-01-29

4. A case of epidermal growth factor receptor tyrosine kinase inhibitor effectiveness in epidermal growth factor receptor mutation-positive squamous cell carcinoma;SAGE Open Medical Case Reports;2023-01

5. Osimertinib for Brain Metastasis of Epidermal Growth Factor Receptor-mutated Squamous Cell Lung Cancer;Haigan;2022-02-20